97689880 - MMTS MULTI MINI TABLET SYSTEM

Information

  • Trademark
  • 97689880
  • Serial Number
    97689880
  • Registration Number
    7683627
  • Filing Date
    November 23, 2022
    3 years ago
  • Registration Date
    February 11, 2025
    11 months ago
  • Transaction Date
    July 25, 2025
    6 months ago
  • Status Date
    February 11, 2025
    11 months ago
  • Published for Opposition Date
    June 11, 2024
    a year ago
  • Location Date
    July 24, 2025
    6 months ago
  • Status Code
    700
  • Current Location
    Historical data usage
    Employee Name
    SPARACINO, MARK
  • Attorney Docket Number
    040868
    Attorney Name
    Robert S. Broder
  • Owners
Mark Drawing Code
4
Mark Identification
MMTS MULTI MINI TABLET SYSTEM
Case File Statements
  • GS0401: Manufacturing services to the specification of others in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems, including customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release systems; clinical manufacturing of drug compositions for others to support clinical trials; manufacturing process consulting services for others relating to technology scale-up and integration of technology into manufacturing processes
  • B00001: In the statement, line 14 - 15, "thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia" should be deleted, and "thrombocythemia, hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, should be inserted. line 20, "Alzheimer" should be deleted, and "Alzheimer's" should be inserted.
  • GS0051: Pharmaceutical and veterinary pharmaceutical preparations, in particular drug delivery compositions, drug carriers and drug delivery agents, capsules, sachets and sprinkles for pharmaceutical purposes, comprising multiparticulates or multiple units, used for the treatment of disorders or diseases in the gastrointestinal tract, in the digestive system, in the gut, in the immune systems, in the cardiovascular system, in the respiratory tract, in the blood, in the metabolism, in the nervous system, in the cognition, in the behavior, and in the reproductive tract, gastrointestinal infections, diarrhea, irritable bowel syndrome, inflammatory bowel syndrome disease, enterocolitis, enteritis, ulcerative colitis, cardiovascular disorders, hypertension, thrombosis, vasoconstriction, asthma, inflammation of respiratory tract, asthma, bronchoconstriction, [ thrombonemia, ipertriglyceremia, ipercholesterolemia, iperlipoproteinemia, ] * thrombocythemia ,hypertriglyceridemia, hypercholesterolemia, hyperlipoproteinemia, * blood anemia, hypocalcemia, diabetes, diabetic peripheral neuropathy, dyskinesia, hyperkinetic movements, enzyme deficiency, pancreatitis, pancreatectomy, steatorrhea, cystic fibrosis, Paget's disease, bacterial infections, viral infections, fungal infections, osteoporosis, cancer, mucosal and systemic inflammation, functional disease, abdominal pain, allergy, obesity, muscle spasticity, spasms, convulsion, dysthymia, schizophrenia, degenerative dementia, [ Alzheimer, ] * Alzheimer's, * stress, anxiety, depression, mood disturbance, sociability disturbance, sleep disturbance, psychological disturbance, attention deficit hyperactivity disorder, addiction, fibromyalgia, obsessive-compulsive disorders, pain, peripheral neuropathic pain, post-surgical pain, back-pain, osteoarthritis
  • DS0000: "MULTI MINI TABLET SYSTEM"
  • GS0421: Research and development services in the pharmaceutical field and in the veterinary field, in particular in the field of pharmaceutical active substance delivery systems; research and development services for the preparation of multiparticulates or multiple units dosage forms including capsules, sachets, sprinkles; research and development in the area of delivery systems with customized release, taste masked release, immediate release, pulsatile release, extended release, sustained release, and delayed release; scientific research and development in the area of stability testing, physical characterization, in-vitro release testing
Case File Event Statements
  • 11/26/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 12/15/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/6/2023 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/12/2023 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/12/2023 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/12/2023 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/12/2023 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/2/2024 - a year ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 5/2/2024 - a year ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/2/2024 - a year ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/6/2024 - a year ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 5/6/2024 - a year ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/6/2024 - a year ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/6/2024 - a year ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/6/2024 - a year ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/22/2024 - a year ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/11/2024 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/11/2024 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/5/2024 - a year ago
    25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 8/6/2024 - a year ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/5/2024 - a year ago
    22 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/5/2024 - a year ago
    21 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 12/5/2024 - a year ago
    23 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/5/2024 - a year ago
    20 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 12/5/2024 - a year ago
    24 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 12/9/2024 - a year ago
    26 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 1/22/2025 - a year ago
    27 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 1/22/2025 - a year ago
    28 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 7/14/2025 - 6 months ago
    32 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 7/24/2025 - 6 months ago
    33 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 2/11/2025 - 11 months ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/11/2025 - 11 months ago
    30 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 2/18/2025 - 11 months ago
    31 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R